ID
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
sequence | ner_tags
sequence |
|---|---|---|---|---|---|
NCT01614990 | 38:50:treatment | subjects may otherwise be undergoing chemotherapy | 1 | [
"subjects",
"may",
"otherwise",
"be",
"undergoing",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
1
] |
NCT01526603 | 43:55:treatment, | Patients who are delayed in consolidation chemotherapy beyond 8 weeks | 1 | [
"Patients",
"who",
"are",
"delayed",
"in",
"consolidation",
"chemotherapy",
"beyond",
"8",
"weeks"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT01526603 | 40:52:treatment | Recovery from last induction course of chemotherapy | 1 | [
"Recovery",
"from",
"last",
"induction",
"course",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
1
] |
NCT01515527 | 74:86:treatment | Patient with documented hypersensitivity to any of the components of the chemotherapy program | 1 | [
"Patient",
"with",
"documented",
"hypersensitivity",
"to",
"any",
"of",
"the",
"components",
"of",
"the",
"chemotherapy",
"program"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01505569 | 48:60:treatment | Timing: Recovery from last induction course of chemotherapy | 1 | [
"Timing",
":",
"Recovery",
"from",
"last",
"induction",
"course",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01434316 | 7:19:treatment | Prior chemotherapy | 1 | [
"Prior",
"chemotherapy"
] | [
0,
1
] |
NCT01238120 | 63:75:treatment | Patients with a neutropenic episode during the first cycle of chemotherapy or at high risk for a neutropenic episode during future chemotherapy cycles at the treating physicians discretion | 1 | [
"Patients",
"with",
"a",
"neutropenic",
"episode",
"during",
"the",
"first",
"cycle",
"of",
"chemotherapy",
"or",
"at",
"high",
"risk",
"for",
"a",
"neutropenic",
"episode",
"during",
"future",
"chemotherapy",
"cycles",
"at",
"the",
"treating",
"physicians",
"discretion"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01061515 | 41:53:treatment | All patients must be consented prior to chemotherapy | 1 | [
"All",
"patients",
"must",
"be",
"consented",
"prior",
"to",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01061515 | 53:65:treatment,,,, | Patients must have adequate renal function prior to chemotherapy defined as serum creatinine ≤ 2.0 mg/dl or creatinine clearance ≥60 ml.min/1.73 m² for patients with creatinine levels above 2.0 mg/dl | 1 | [
"Patients",
"must",
"have",
"adequate",
"renal",
"function",
"prior",
"to",
"chemotherapy",
"defined",
"as",
"serum",
"creatinine",
"≤",
"2.0",
"mg/dl",
"or",
"creatinine",
"clearance",
"≥60",
"ml.min/1.73",
"m²",
"for",
"patients",
"with",
"creatinine",
"levels",
"above",
"2.0",
"mg/dl"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01061515 | 21:33:treatment | have received prior chemotherapy | 1 | [
"have",
"received",
"prior",
"chemotherapy"
] | [
0,
0,
0,
1
] |
NCT01061515 | 105:117:treatment | must undergo a peritoneal scan documenting at least one working intraperitoneal port prior to receiving chemotherapy | 1 | [
"must",
"undergo",
"a",
"peritoneal",
"scan",
"documenting",
"at",
"least",
"one",
"working",
"intraperitoneal",
"port",
"prior",
"to",
"receiving",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT00911560 | ,,178:190:treatment | stage 4 with (any age) or without (>18 months old) MYCN amplification, MYCN-amplified stage 3 (unresectable; any age), MYCN-amplified stage 4S, or disease resistant to standard chemotherapy | 1 | [
"stage",
"4",
"with",
"(",
"any",
"age",
")",
"or",
"without",
"(",
">",
"18",
"months",
"old",
")",
"MYCN",
"amplification",
",",
"MYCN-amplified",
"stage",
"3",
"(",
"unresectable",
";",
"any",
"age",
")",
",",
"MYCN-amplified",
"stage",
"4S",
",",
"or",
"disease",
"resistant",
"to",
"standard",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT00902720 | 1:13:treatment | chemotherapy | 1 | [
"chemotherapy"
] | [
1
] |
NCT00819208 | 63:75:treatment | patients who are pre-planned to receive a shorter duration of chemotherapy, including as part of a research study | 1 | [
"patients",
"who",
"are",
"pre-planned",
"to",
"receive",
"a",
"shorter",
"duration",
"of",
"chemotherapy",
",",
"including",
"as",
"part",
"of",
"a",
"research",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00719888 | ,,97:109:treatment | ligible with (M2 marrow) with =< 25% blasts in marrow after having failed one or more cycles of chemotherapy | 1 | [
"ligible",
"with",
"(",
"M2",
"marrow",
")",
"with",
"=",
"<",
"25",
"%",
"blasts",
"in",
"marrow",
"after",
"having",
"failed",
"one",
"or",
"more",
"cycles",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT00719888 | ,81:93:treatment | patients persistently aplastic for greater than one month since completing last chemotherapy are also eligible with PI approval | 1 | [
"patients",
"persistently",
"aplastic",
"for",
"greater",
"than",
"one",
"month",
"since",
"completing",
"last",
"chemotherapy",
"are",
"also",
"eligible",
"with",
"PI",
"approval"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT00632853 | 1:13:treatment | chemotherapy | 1 | [
"chemotherapy"
] | [
1
] |
NCT00632853 | 115:127:treatment | patients also must have met all of the eligibility criteria in the protocol prior to receiving the first cycle of chemotherapy | 1 | [
"patients",
"also",
"must",
"have",
"met",
"all",
"of",
"the",
"eligibility",
"criteria",
"in",
"the",
"protocol",
"prior",
"to",
"receiving",
"the",
"first",
"cycle",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT00501826 | 36:48:treatment | failure to one induction course of chemotherapy are eligible | 1 | [
"failure",
"to",
"one",
"induction",
"course",
"of",
"chemotherapy",
"are",
"eligible"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT00492778 | 23:35:treatment | Patients who received chemotherapy directed at the present recurrence | 1 | [
"Patients",
"who",
"received",
"chemotherapy",
"directed",
"at",
"the",
"present",
"recurrence"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT00107289 | 52:64:treatment | Three weeks should have elapsed since last dose of chemotherapy | 1 | [
"Three",
"weeks",
"should",
"have",
"elapsed",
"since",
"last",
"dose",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03171493 | ,,98:107:treatment | Men or women of childbearing potential who are unwilling to employ adequate contraception during treatment and 8 weeks following the completion of study drug treatment | 1 | [
"Men",
"or",
"women",
"of",
"childbearing",
"potential",
"who",
"are",
"unwilling",
"to",
"employ",
"adequate",
"contraception",
"during",
"treatment",
"and",
"8",
"weeks",
"following",
"the",
"completion",
"of",
"study",
"drug",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03158974 | ,,102:111:treatment, | If female of childbearing potential, must have a negative urine pregnancy test result prior to study treatment and must be willing to use a barrier method of birth control while enrolled in the study | 1 | [
"If",
"female",
"of",
"childbearing",
"potential",
",",
"must",
"have",
"a",
"negative",
"urine",
"pregnancy",
"test",
"result",
"prior",
"to",
"study",
"treatment",
"and",
"must",
"be",
"willing",
"to",
"use",
"a",
"barrier",
"method",
"of",
"birth",
"control",
"while",
"enrolled",
"in",
"the",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03158974 | 14:23:treatment,, | Received any treatment for their EGW within 60 days of planned study enrollment | 1 | [
"Received",
"any",
"treatment",
"for",
"their",
"EGW",
"within",
"60",
"days",
"of",
"planned",
"study",
"enrollment"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03154567 | 144:153:treatment | Candidates must meet DSM-5 criteria for Mild-to-Moderate Cannabis Use Disorder (CUD) and be willing to participate in research but not seeking treatment | 1 | [
"Candidates",
"must",
"meet",
"DSM-5",
"criteria",
"for",
"Mild-to-Moderate",
"Cannabis",
"Use",
"Disorder",
"(",
"CUD",
")",
"and",
"be",
"willing",
"to",
"participate",
"in",
"research",
"but",
"not",
"seeking",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03153982 | 86:95:treatment | Prisoners or subjects who are compulsorily detained (involuntarily incarcerated) for treatment of either a psychiatric or physical (e.g., infectious) illness | 1 | [
"Prisoners",
"or",
"subjects",
"who",
"are",
"compulsorily",
"detained",
"(",
"involuntarily",
"incarcerated",
")",
"for",
"treatment",
"of",
"either",
"a",
"psychiatric",
"or",
"physical",
"(",
"e.g.",
",",
"infectious",
")",
"illness"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03137771 | ,,133:142:treatment, | willing and able to use medically acceptable forms of contraception during the trial and for up to 180 days after completion of all treatment to prevent pregnancy or fathering a child | 1 | [
"willing",
"and",
"able",
"to",
"use",
"medically",
"acceptable",
"forms",
"of",
"contraception",
"during",
"the",
"trial",
"and",
"for",
"up",
"to",
"180",
"days",
"after",
"completion",
"of",
"all",
"treatment",
"to",
"prevent",
"pregnancy",
"or",
"fathering",
"a",
"child"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT03127826 | 19:28:treatment | Already receiving treatment (other than primary care) for this episode of LBP | 1 | [
"Already",
"receiving",
"treatment",
"(",
"other",
"than",
"primary",
"care",
")",
"for",
"this",
"episode",
"of",
"LBP"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03115398 | ,65:74:treatment, | Agree to utilize an adequate method of contraception throughout treatment and for at least 4 weeks after study therapy is completed | 1 | [
"Agree",
"to",
"utilize",
"an",
"adequate",
"method",
"of",
"contraception",
"throughout",
"treatment",
"and",
"for",
"at",
"least",
"4",
"weeks",
"after",
"study",
"therapy",
"is",
"completed"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03085784 | ,,,131:140:treatment, | Sexually active men* or women of childbearing potential** who are unwilling to practice adequate contraception start of the first treatment, during the study, and for at least 3 months after the last dose | 1 | [
"Sexually",
"active",
"men",
"*",
"or",
"women",
"of",
"childbearing",
"potential",
"*",
"*",
"who",
"are",
"unwilling",
"to",
"practice",
"adequate",
"contraception",
"start",
"of",
"the",
"first",
"treatment",
",",
"during",
"the",
"study",
",",
"and",
"for",
"at",
"least",
"3",
"months",
"after",
"the",
"last",
"dose"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03077243 | ,61:70:treatment | Adequate renal and hepatic function within 4 weeks prior to treatment | 1 | [
"Adequate",
"renal",
"and",
"hepatic",
"function",
"within",
"4",
"weeks",
"prior",
"to",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03077243 | ,,51:60:treatment | CBC/differential obtained within 8 weeks prior to treatment, with adequate bone marrow | 1 | [
"CBC/differential",
"obtained",
"within",
"8",
"weeks",
"prior",
"to",
"treatment",
",",
"with",
"adequate",
"bone",
"marrow"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT03070899 | ,49:58:treatment | planning a pregnancy within the duration of the treatment period of the study | 1 | [
"planning",
"a",
"pregnancy",
"within",
"the",
"duration",
"of",
"the",
"treatment",
"period",
"of",
"the",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT03045341 | 35:44:treatment | Available for the duration of the treatment and follow-up (20 months) | 1 | [
"Available",
"for",
"the",
"duration",
"of",
"the",
"treatment",
"and",
"follow-up",
"(",
"20",
"months",
")"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT03042689 | 24:33:treatment | Previous assignment to treatment during this study | 1 | [
"Previous",
"assignment",
"to",
"treatment",
"during",
"this",
"study"
] | [
0,
0,
0,
1,
0,
0,
0
] |
NCT03033212 | ,42:51:treatment | Failed at least 3 months of conservative treatment | 1 | [
"Failed",
"at",
"least",
"3",
"months",
"of",
"conservative",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03025828 | ,26:35:treatment | More than three previous treatment regiments | 1 | [
"More",
"than",
"three",
"previous",
"treatment",
"regiments"
] | [
0,
0,
0,
0,
1,
0
] |
NCT03013543 | 44:53:treatment | Patient completes the initial ~3 months of treatment period without evidence of severe or clinically relevant adverse events, changes in vital signs, or changes in safety laboratories or ECGs | 1 | [
"Patient",
"completes",
"the",
"initial",
"~3",
"months",
"of",
"treatment",
"period",
"without",
"evidence",
"of",
"severe",
"or",
"clinically",
"relevant",
"adverse",
"events",
",",
"changes",
"in",
"vital",
"signs",
",",
"or",
"changes",
"in",
"safety",
"laboratories",
"or",
"ECGs"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02932280 | ,,87:96:treatment, | Male patients must agree and commit to use a barrier method of contraception while on treatment and for 3 months after the last dose of the investigational product | 1 | [
"Male",
"patients",
"must",
"agree",
"and",
"commit",
"to",
"use",
"a",
"barrier",
"method",
"of",
"contraception",
"while",
"on",
"treatment",
"and",
"for",
"3",
"months",
"after",
"the",
"last",
"dose",
"of",
"the",
"investigational",
"product"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02907944 | 108:117:treatment | Meets criteria for lifetime or current tobacco, alcohol and/or opioid use disorder regardless of addiction treatment status | 1 | [
"Meets",
"criteria",
"for",
"lifetime",
"or",
"current",
"tobacco",
",",
"alcohol",
"and/or",
"opioid",
"use",
"disorder",
"regardless",
"of",
"addiction",
"treatment",
"status"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02863991 | ,,,82:91:treatment | Absolute neutrophil count ≥1,000/mm3 without growth factor use ≤ 7 days prior to treatment (cycle 1 day 1, C1D1) | 1 | [
"Absolute",
"neutrophil",
"count",
"≥1,000/mm3",
"without",
"growth",
"factor",
"use",
"≤",
"7",
"days",
"prior",
"to",
"treatment",
"(",
"cycle",
"1",
"day",
"1",
",",
"C1D1",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02863991 | ,,,187:196:treatment | Female patients must be surgically sterile or be postmenopausal, or must agree to use effective contraception during the period of the trial and for at least 90 days after completion of treatment | 1 | [
"Female",
"patients",
"must",
"be",
"surgically",
"sterile",
"or",
"be",
"postmenopausal",
",",
"or",
"must",
"agree",
"to",
"use",
"effective",
"contraception",
"during",
"the",
"period",
"of",
"the",
"trial",
"and",
"for",
"at",
"least",
"90",
"days",
"after",
"completion",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02836574 | 8:17:treatment,, | Stable treatment is defined as dose adjustment to no less than one half of the current dosage or to no more than 2 times the current dosage | 1 | [
"Stable",
"treatment",
"is",
"defined",
"as",
"dose",
"adjustment",
"to",
"no",
"less",
"than",
"one",
"half",
"of",
"the",
"current",
"dosage",
"or",
"to",
"no",
"more",
"than",
"2",
"times",
"the",
"current",
"dosage"
] | [
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02799095 | ,,,101:110:treatment | Females of childbearing potential must have a negative pregnancy test within 7 days of the start of treatment and on Day 1 before the first dose is administered | 1 | [
"Females",
"of",
"childbearing",
"potential",
"must",
"have",
"a",
"negative",
"pregnancy",
"test",
"within",
"7",
"days",
"of",
"the",
"start",
"of",
"treatment",
"and",
"on",
"Day",
"1",
"before",
"the",
"first",
"dose",
"is",
"administered"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02780401 | 59:68:treatment, | History of autoimmunity that has not been controlled with treatment in the last 12 months | 1 | [
"History",
"of",
"autoimmunity",
"that",
"has",
"not",
"been",
"controlled",
"with",
"treatment",
"in",
"the",
"last",
"12",
"months"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02762266 | ,,37:46:treatment | with score =< 9 ((within 4 weeks of treatment) | 1 | [
"with",
"score",
"=",
"<",
"9",
"(",
"(",
"within",
"4",
"weeks",
"of",
"treatment",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02753283 | 62:71:treatment | Those with a history of hypocalcemia or contraindication for treatment | 1 | [
"Those",
"with",
"a",
"history",
"of",
"hypocalcemia",
"or",
"contraindication",
"for",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02725177 | ,,,,,,,,,,,326:335:treatment | Women of childbearing potential must be using adequate birth control measures (abstinence, hormonal contraceptives, intrauterine device, barrier method with spermicide, or surgical sterilization) and must agree to continue such precautions, and not become pregnant or plan a pregnancy for 6 months after receiving their last treatment with study agent | 1 | [
"Women",
"of",
"childbearing",
"potential",
"must",
"be",
"using",
"adequate",
"birth",
"control",
"measures",
"(",
"abstinence",
",",
"hormonal",
"contraceptives",
",",
"intrauterine",
"device",
",",
"barrier",
"method",
"with",
"spermicide",
",",
"or",
"surgical",
"sterilization",
")",
"and",
"must",
"agree",
"to",
"continue",
"such",
"precautions",
",",
"and",
"not",
"become",
"pregnant",
"or",
"plan",
"a",
"pregnancy",
"for",
"6",
"months",
"after",
"receiving",
"their",
"last",
"treatment",
"with",
"study",
"agent"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02656706 | ,,122:131:treatment | must agree to use adequate barrier birth control measures during the course of the study and up to 2 months after end of treatment | 1 | [
"must",
"agree",
"to",
"use",
"adequate",
"barrier",
"birth",
"control",
"measures",
"during",
"the",
"course",
"of",
"the",
"study",
"and",
"up",
"to",
"2",
"months",
"after",
"end",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02654236 | ,,93:102:treatment | Women of child bearing potential should be willing to practice contraception throughout the treatment period | 1 | [
"Women",
"of",
"child",
"bearing",
"potential",
"should",
"be",
"willing",
"to",
"practice",
"contraception",
"throughout",
"the",
"treatment",
"period"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02639065 | 99:108:treatment | Because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother, breastfeeding should be discontinued | 1 | [
"Because",
"there",
"is",
"an",
"unknown",
"but",
"potential",
"risk",
"for",
"adverse",
"events",
"in",
"nursing",
"infants",
"secondary",
"to",
"treatment",
"of",
"the",
"mother",
",",
"breastfeeding",
"should",
"be",
"discontinued"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02639065 | ,,,,216:225:treatment | Females of childbearing potential and males must be willing to use an effective method of contraception (hormonal or barrier method of birth control; abstinence) from the time consent is signed until 12 weeks after treatment discontinuation | 1 | [
"Females",
"of",
"childbearing",
"potential",
"and",
"males",
"must",
"be",
"willing",
"to",
"use",
"an",
"effective",
"method",
"of",
"contraception",
"(",
"hormonal",
"or",
"barrier",
"method",
"of",
"birth",
"control",
";",
"abstinence",
")",
"from",
"the",
"time",
"consent",
"is",
"signed",
"until",
"12",
"weeks",
"after",
"treatment",
"discontinuation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02593526 | 30:39:treatment | History of poor adherence to treatment | 1 | [
"History",
"of",
"poor",
"adherence",
"to",
"treatment"
] | [
0,
0,
0,
0,
0,
1
] |
NCT02592551 | 106:115:treatment | Any condition that, in the opinion of the investigator, would interfere with the evaluation of the study treatment or interpretation of subject safety or study results | 1 | [
"Any",
"condition",
"that",
",",
"in",
"the",
"opinion",
"of",
"the",
"investigator",
",",
"would",
"interfere",
"with",
"the",
"evaluation",
"of",
"the",
"study",
"treatment",
"or",
"interpretation",
"of",
"subject",
"safety",
"or",
"study",
"results"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02589522 | ,,73:82:treatment | Life expectance of greater than two months to allow completion of study treatment and assessment of dose-limiting toxicity | 1 | [
"Life",
"expectance",
"of",
"greater",
"than",
"two",
"months",
"to",
"allow",
"completion",
"of",
"study",
"treatment",
"and",
"assessment",
"of",
"dose-limiting",
"toxicity"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02587312 | 30:39:treatment, | Participants who are seeking treatment for their smoking or who report that they intend to quit smoking within the next 30 days and have made a 24-hour quit attempt in the past year | 1 | [
"Participants",
"who",
"are",
"seeking",
"treatment",
"for",
"their",
"smoking",
"or",
"who",
"report",
"that",
"they",
"intend",
"to",
"quit",
"smoking",
"within",
"the",
"next",
"30",
"days",
"and",
"have",
"made",
"a",
"24-hour",
"quit",
"attempt",
"in",
"the",
"past",
"year"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02585973 | 4:13:treatment | Co-treatment with weak inhibitors of CYP3A4 | 1 | [
"Co-treatment",
"with",
"weak",
"inhibitors",
"of",
"CYP3A4"
] | [
1,
0,
0,
0,
0,
0
] |
NCT02585973 | ,,,106:115:treatment | Women of childbearing potential (WOCBP) must have negative pregnancy test within 72 hours prior to D1 of treatment | 1 | [
"Women",
"of",
"childbearing",
"potential",
"(",
"WOCBP",
")",
"must",
"have",
"negative",
"pregnancy",
"test",
"within",
"72",
"hours",
"prior",
"to",
"D1",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02584647 | ,,,,,,150:159:treatment | Creatinine ≤ 1.5 x ULN or calculated creatinine clearance (CrCl) > 60 mL/min using the Cockcroft-Gault formula less than eight days pior to start of treatment | 1 | [
"Creatinine",
"≤",
"1.5",
"x",
"ULN",
"or",
"calculated",
"creatinine",
"clearance",
"(",
"CrCl",
")",
">",
"60",
"mL/min",
"using",
"the",
"Cockcroft-Gault",
"formula",
"less",
"than",
"eight",
"days",
"pior",
"to",
"start",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02582775 | ,,104:113:treatment | Available donor per section 5: targeted MFI < 1,000 (MFI exceeding 1000 must be approved by the PI and treatment team.) | 1 | [
"Available",
"donor",
"per",
"section",
"5",
":",
"targeted",
"MFI",
"<",
"1,000",
"(",
"MFI",
"exceeding",
"1000",
"must",
"be",
"approved",
"by",
"the",
"PI",
"and",
"treatment",
"team",
".",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02582775 | 112:121:treatment | adult or parent (with information sheet for minors, if applicable) prior to any research related procedures or treatment | 1 | [
"adult",
"or",
"parent",
"(",
"with",
"information",
"sheet",
"for",
"minors",
",",
"if",
"applicable",
")",
"prior",
"to",
"any",
"research",
"related",
"procedures",
"or",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02581215 | 29:38:treatment | Known allergy to any of the treatment components | 1 | [
"Known",
"allergy",
"to",
"any",
"of",
"the",
"treatment",
"components"
] | [
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02579044 | ,,169:178:treatment | Sexually active male and female subjects of reproductive potential must agree to use a medically accepted form of birth control while on study and up to 10 weeks after treatment | 1 | [
"Sexually",
"active",
"male",
"and",
"female",
"subjects",
"of",
"reproductive",
"potential",
"must",
"agree",
"to",
"use",
"a",
"medically",
"accepted",
"form",
"of",
"birth",
"control",
"while",
"on",
"study",
"and",
"up",
"to",
"10",
"weeks",
"after",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02578901 | 50:59:treatment | Able to provide informed consent and comply with treatment and monitoring, or having a Legally Authorized Representative (LAR) | 1 | [
"Able",
"to",
"provide",
"informed",
"consent",
"and",
"comply",
"with",
"treatment",
"and",
"monitoring",
",",
"or",
"having",
"a",
"Legally",
"Authorized",
"Representative",
"(",
"LAR",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02578901 | 71:80:treatment | Having been previously randomized in this study at any stage of their treatment | 1 | [
"Having",
"been",
"previously",
"randomized",
"in",
"this",
"study",
"at",
"any",
"stage",
"of",
"their",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02578732 | ,,,,,178:187:treatment | Women of child bearing potential must have a negative serum or urine pregnancy test (minimum sensitivity 25 IU/L or equivalent units of HCG) within 7 days prior to beginning of treatment | 1 | [
"Women",
"of",
"child",
"bearing",
"potential",
"must",
"have",
"a",
"negative",
"serum",
"or",
"urine",
"pregnancy",
"test",
"(",
"minimum",
"sensitivity",
"25",
"IU/L",
"or",
"equivalent",
"units",
"of",
"HCG",
")",
"within",
"7",
"days",
"prior",
"to",
"beginning",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02577406 | ,,,61:70:treatment | at least 5% leukemic blasts in bone marrow after at least 2 treatment cycles | 1 | [
"at",
"least",
"5",
"%",
"leukemic",
"blasts",
"in",
"bone",
"marrow",
"after",
"at",
"least",
"2",
"treatment",
"cycles"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02576444 | ,67:76:treatment | Inadequate bone marrow reserve within past 28 days prior to study treatment | 1 | [
"Inadequate",
"bone",
"marrow",
"reserve",
"within",
"past",
"28",
"days",
"prior",
"to",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02576444 | 108:117:treatment | Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up | 1 | [
"Patient",
"is",
"willing",
"and",
"able",
"to",
"comply",
"with",
"the",
"protocol",
"for",
"the",
"duration",
"of",
"the",
"study",
"including",
"undergoing",
"treatment",
"and",
"scheduled",
"visits",
"and",
"examinations",
"including",
"follow",
"up"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02576444 | 103:112:treatment | Patient must not have a co-morbid condition(s) that, in the opinion of the investigator, prevent safe treatment | 1 | [
"Patient",
"must",
"not",
"have",
"a",
"co-morbid",
"condition",
"(",
"s",
")",
"that",
",",
"in",
"the",
"opinion",
"of",
"the",
"investigator",
",",
"prevent",
"safe",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02576431 | ,44:53:treatment | Subjects who received less than 28 days of treatment and discontinued because of intolerance or toxicity are eligible | 1 | [
"Subjects",
"who",
"received",
"less",
"than",
"28",
"days",
"of",
"treatment",
"and",
"discontinued",
"because",
"of",
"intolerance",
"or",
"toxicity",
"are",
"eligible"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02575404 | ,,33:42:treatment | Pregnant or lactating women, as treatment involves unforeseeable risks to the embryo or fetus | 1 | [
"Pregnant",
"or",
"lactating",
"women",
",",
"as",
"treatment",
"involves",
"unforeseeable",
"risks",
"to",
"the",
"embryo",
"or",
"fetus"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02575404 | ,,,132:141:treatment | Women of childbearing potential must have a serum or urine pregnancy test performed within 72 hours prior to the start of protocol treatment | 1 | [
"Women",
"of",
"childbearing",
"potential",
"must",
"have",
"a",
"serum",
"or",
"urine",
"pregnancy",
"test",
"performed",
"within",
"72",
"hours",
"prior",
"to",
"the",
"start",
"of",
"protocol",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02573493 | ,,,,,,,237:246:treatment | Women of childbearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control, abstinence) prior to study entry, for the duration of study participation, and for 3 months after completing treatment | 1 | [
"Women",
"of",
"childbearing",
"potential",
"and",
"men",
"must",
"agree",
"to",
"use",
"adequate",
"contraception",
"(",
"hormonal",
"or",
"barrier",
"method",
"of",
"birth",
"control",
",",
"abstinence",
")",
"prior",
"to",
"study",
"entry",
",",
"for",
"the",
"duration",
"of",
"study",
"participation",
",",
"and",
"for",
"3",
"months",
"after",
"completing",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02560766 | ,,,,,,,,308:317:treatment, | Sexually active patients must agree to use 2 medically accepted methods of contraception, 1 of which is a highly effective method (e.g., hormonal or intrauterine device [IUD]) [the second may be a barrier method (e.g., male condom, female condom, diaphragm or cervical cap)], during the course of the study treatment and for 4 weeks after the last dose of study treatment | 1 | [
"Sexually",
"active",
"patients",
"must",
"agree",
"to",
"use",
"2",
"medically",
"accepted",
"methods",
"of",
"contraception",
",",
"1",
"of",
"which",
"is",
"a",
"highly",
"effective",
"method",
"(",
"e.g.",
",",
"hormonal",
"or",
"intrauterine",
"device",
"[",
"IUD",
"]",
")",
"[",
"the",
"second",
"may",
"be",
"a",
"barrier",
"method",
"(",
"e.g.",
",",
"male",
"condom",
",",
"female",
"condom",
",",
"diaphragm",
"or",
"cervical",
"cap",
")",
"]",
",",
"during",
"the",
"course",
"of",
"the",
"study",
"treatment",
"and",
"for",
"4",
"weeks",
"after",
"the",
"last",
"dose",
"of",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02555280 | 27:36:treatment | Appropriate candidate for treatment using posterior surgical approach | 1 | [
"Appropriate",
"candidate",
"for",
"treatment",
"using",
"posterior",
"surgical",
"approach"
] | [
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02555280 | 123:132:treatment | Psychosocially, mentally, and physically able to fully comply with this protocol, including adhering to scheduled visits, treatment plan, completing forms, and other study procedures | 1 | [
"Psychosocially",
",",
"mentally",
",",
"and",
"physically",
"able",
"to",
"fully",
"comply",
"with",
"this",
"protocol",
",",
"including",
"adhering",
"to",
"scheduled",
"visits",
",",
"treatment",
"plan",
",",
"completing",
"forms",
",",
"and",
"other",
"study",
"procedures"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02555189 | ,,,120:129:treatment, | Sexually active males unless they use a condom during intercourse while taking the drug and for 30 days after stopping treatment and should not father a child in this period. A condom is required to be used by vasectomized men in order to prevent delivery of the drug via seminal fluid | 1 | [
"Sexually",
"active",
"males",
"unless",
"they",
"use",
"a",
"condom",
"during",
"intercourse",
"while",
"taking",
"the",
"drug",
"and",
"for",
"30",
"days",
"after",
"stopping",
"treatment",
"and",
"should",
"not",
"father",
"a",
"child",
"in",
"this",
"period",
".",
"A",
"condom",
"is",
"required",
"to",
"be",
"used",
"by",
"vasectomized",
"men",
"in",
"order",
"to",
"prevent",
"delivery",
"of",
"the",
"drug",
"via",
"seminal",
"fluid"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02554903 | ,,101:110:treatment | Agreement to undertake monthly serum pregnancy tests during the study and up to 30 days after study treatment discontinuation | 1 | [
"Agreement",
"to",
"undertake",
"monthly",
"serum",
"pregnancy",
"tests",
"during",
"the",
"study",
"and",
"up",
"to",
"30",
"days",
"after",
"study",
"treatment",
"discontinuation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02553447 | 111:120:treatment | Patients must have histologically confirmed newly diagnosed or previously untreated (patients may be under no treatment | 1 | [
"Patients",
"must",
"have",
"histologically",
"confirmed",
"newly",
"diagnosed",
"or",
"previously",
"untreated",
"(",
"patients",
"may",
"be",
"under",
"no",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02542202 | ,,,158:167:treatment, | Pregnancy or women of childbearing potential who are sexually active and not willing/able to use medically acceptable forms of contraception during protocol treatment or for at least 6 months following treatment | 1 | [
"Pregnancy",
"or",
"women",
"of",
"childbearing",
"potential",
"who",
"are",
"sexually",
"active",
"and",
"not",
"willing/able",
"to",
"use",
"medically",
"acceptable",
"forms",
"of",
"contraception",
"during",
"protocol",
"treatment",
"or",
"for",
"at",
"least",
"6",
"months",
"following",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02535923 | 103:112:treatment | Current problematic drug or alcohol use that impacts functioning and study engagement, as deemed by a treatment provider | 1 | [
"Current",
"problematic",
"drug",
"or",
"alcohol",
"use",
"that",
"impacts",
"functioning",
"and",
"study",
"engagement",
",",
"as",
"deemed",
"by",
"a",
"treatment",
"provider"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02535923 | 61:70:treatment | Sufficient clinical stability to participate as deemed by a treatment provider | 1 | [
"Sufficient",
"clinical",
"stability",
"to",
"participate",
"as",
"deemed",
"by",
"a",
"treatment",
"provider"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02533674 | 56:65:treatment | Limitation of the patient's ability to comply with the treatment or follow-up protocol | 1 | [
"Limitation",
"of",
"the",
"patient",
"'s",
"ability",
"to",
"comply",
"with",
"the",
"treatment",
"or",
"follow-up",
"protocol"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02532621 | ,59:68:treatment | The patient has had >2 previous arteriovenous accesses in treatment arm | 1 | [
"The",
"patient",
"has",
"had",
">",
"2",
"previous",
"arteriovenous",
"accesses",
"in",
"treatment",
"arm"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02532543 | 41:50:treatment | Previous enrollment or randomization of treatment in the present study | 1 | [
"Previous",
"enrollment",
"or",
"randomization",
"of",
"treatment",
"in",
"the",
"present",
"study"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02531932 | ,,63:72:treatment | Negative serum pregnancy test within 7 days prior to starting treatment | 1 | [
"Negative",
"serum",
"pregnancy",
"test",
"within",
"7",
"days",
"prior",
"to",
"starting",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02530034 | ,,,,,,,,,305:314:treatment | Women of child-bearing potential (i.e., women who are pre-menopausal or not surgically sterile) must use acceptable contraceptive methods (abstinence, intrauterine device [IUD], oral contraceptive or double barrier device), and must have a negative urine pregnancy test within 2 weeks prior to beginning treatment on this trial | 1 | [
"Women",
"of",
"child-bearing",
"potential",
"(",
"i.e.",
",",
"women",
"who",
"are",
"pre-menopausal",
"or",
"not",
"surgically",
"sterile",
")",
"must",
"use",
"acceptable",
"contraceptive",
"methods",
"(",
"abstinence",
",",
"intrauterine",
"device",
"[",
"IUD",
"]",
",",
"oral",
"contraceptive",
"or",
"double",
"barrier",
"device",
")",
",",
"and",
"must",
"have",
"a",
"negative",
"urine",
"pregnancy",
"test",
"within",
"2",
"weeks",
"prior",
"to",
"beginning",
"treatment",
"on",
"this",
"trial"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02527200 | 14:23:treatment | No change in treatment plan with growth hormone (GH) from randomisation to the end of the open-label period patients on growth hormone to stay on, patients off GH to stay off during this period. Adjustments in doses of growth hormone will be permitted) | 1 | [
"No",
"change",
"in",
"treatment",
"plan",
"with",
"growth",
"hormone",
"(",
"GH",
")",
"from",
"randomisation",
"to",
"the",
"end",
"of",
"the",
"open-label",
"period",
"patients",
"on",
"growth",
"hormone",
"to",
"stay",
"on",
",",
"patients",
"off",
"GH",
"to",
"stay",
"off",
"during",
"this",
"period",
".",
"Adjustments",
"in",
"doses",
"of",
"growth",
"hormone",
"will",
"be",
"permitted",
")"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02524275 | ,,,,194:203:treatment | Women of reproductive potential must be non-pregnant and non-nursing and must agree to employ an effective barrier method of birth control throughout the study and for up to 6 months following treatment | 1 | [
"Women",
"of",
"reproductive",
"potential",
"must",
"be",
"non-pregnant",
"and",
"non-nursing",
"and",
"must",
"agree",
"to",
"employ",
"an",
"effective",
"barrier",
"method",
"of",
"birth",
"control",
"throughout",
"the",
"study",
"and",
"for",
"up",
"to",
"6",
"months",
"following",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02519322 | ,,,52:61:treatment | Albumin >= 2.5 g/dL (within 28 days of first study treatment) | 1 | [
"Albumin",
">",
"=",
"2.5",
"g/dL",
"(",
"within",
"28",
"days",
"of",
"first",
"study",
"treatment",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02519322 | ,,,52:61:treatment | Amylase < 1.5 X ULN (within 28 days of first study treatment) | 1 | [
"Amylase",
"<",
"1.5",
"X",
"ULN",
"(",
"within",
"28",
"days",
"of",
"first",
"study",
"treatment",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02519322 | ,,,55:64:treatment | Hemoglobin >= 8.5 g/dL (within 28 days of first study treatment) | 1 | [
"Hemoglobin",
">",
"=",
"8.5",
"g/dL",
"(",
"within",
"28",
"days",
"of",
"first",
"study",
"treatment",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02519322 | ,,,51:60:treatment | Lipase < 1.5 X ULN (within 28 days of first study treatment) | 1 | [
"Lipase",
"<",
"1.5",
"X",
"ULN",
"(",
"within",
"28",
"days",
"of",
"first",
"study",
"treatment",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02519322 | ,,,,166:175:treatment | Prothrombin time (PT)/international normalized ratio (INR) and partial thromboplastin time (PTT) =< 1.5 X upper limit of normal (ULN) (within 28 days of first study treatment) | 1 | [
"Prothrombin",
"time",
"(",
"PT",
")",
"/international",
"normalized",
"ratio",
"(",
"INR",
")",
"and",
"partial",
"thromboplastin",
"time",
"(",
"PTT",
")",
"=",
"<",
"1.5",
"X",
"upper",
"limit",
"of",
"normal",
"(",
"ULN",
")",
"(",
"within",
"28",
"days",
"of",
"first",
"study",
"treatment",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02519322 | ,,,72:81:treatment | White blood cells (WBC) >= 2.0 X 10^9/L (within 28 days of first study treatment) | 1 | [
"White",
"blood",
"cells",
"(",
"WBC",
")",
">",
"=",
"2.0",
"X",
"10^9/L",
"(",
"within",
"28",
"days",
"of",
"first",
"study",
"treatment",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02519322 | ,39:48:treatment | Within 2 weeks prior to time of study treatment | 1 | [
"Within",
"2",
"weeks",
"prior",
"to",
"time",
"of",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02519322 | ,,,,,248:257:treatment | subjects with TnT or TnI levels between > 1 to 2 x ULN will be permitted if repeat levels within 24 hours are </= 1 x ULN; if TnT or TnI levels are > 1 to 2 x ULN within 24 hours, the subject may undergo a cardiac evaluation and be considered for treatment, following a discussion with the investigator or designee | 1 | [
"subjects",
"with",
"TnT",
"or",
"TnI",
"levels",
"between",
">",
"1",
"to",
"2",
"x",
"ULN",
"will",
"be",
"permitted",
"if",
"repeat",
"levels",
"within",
"24",
"hours",
"are",
"<",
"/=",
"1",
"x",
"ULN",
";",
"if",
"TnT",
"or",
"TnI",
"levels",
"are",
">",
"1",
"to",
"2",
"x",
"ULN",
"within",
"24",
"hours",
",",
"the",
"subject",
"may",
"undergo",
"a",
"cardiac",
"evaluation",
"and",
"be",
"considered",
"for",
"treatment",
",",
"following",
"a",
"discussion",
"with",
"the",
"investigator",
"or",
"designee"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02515110 | ,,135:144:treatment | Women of child-bearing potential (WCBP) must agree to use a medically accepted form of pregnancy prevention for the duration of study treatment | 1 | [
"Women",
"of",
"child-bearing",
"potential",
"(",
"WCBP",
")",
"must",
"agree",
"to",
"use",
"a",
"medically",
"accepted",
"form",
"of",
"pregnancy",
"prevention",
"for",
"the",
"duration",
"of",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02512926 | ,,,,196:205:treatment | Male and female patients of child-bearing potential must agree to use an effective method of contraception approved by the investigator during the study and for a minimum of 3 months after study treatment | 1 | [
"Male",
"and",
"female",
"patients",
"of",
"child-bearing",
"potential",
"must",
"agree",
"to",
"use",
"an",
"effective",
"method",
"of",
"contraception",
"approved",
"by",
"the",
"investigator",
"during",
"the",
"study",
"and",
"for",
"a",
"minimum",
"of",
"3",
"months",
"after",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |